Investors are advised to stay calm amid volatility, focus on defensive stocks like HUL and NTPC, and watch for explosive ...

The MM-II trial was carried out in partnership with Israel-based Moebius Medical and included 397 patients in the US, Europe, ...

Discover the Sun Pharma Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Sun Pharmaceutical Industries Ltd. closed 8.84% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Some tariffs remain in place against key U.S. trading partners, but others have been postponed to give nations time to ...

Sun Pharmaceutical Industries Ltd. closed 7.94% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Mumbai: Sun Pharma and Israel-based Moebius Medical Limited have announced the publication of two articles in Osteoarthritis ...

Private equity activity in healthcare remained resilient with 42 deals worth $562 million, just shy of last quarter’s $603 ...

If 340B is eliminated or weakened, large pharmaceutical companies will benefit at the expense of health care access across ...

Medical device maker Intuitive Surgical said on Tuesday that U.S. tariffs will increasingly weigh on its business for the rest of the year, disrupting operations in China and potentially eroding its ...

Systematix Group's Vishal Manchanda anticipates Q4 results for pharma companies to align with previous quarters, with high ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.